Published 18 August 2003. doi:10.1083/jcb.200212107
© The Rockefeller University Press,
0021-9525/2003/8/535 $5.00
The Journal of Cell Biology, Volume 162, Number 4, 535-541
Regulation of insulin-like growth factordependent myoblast differentiation by Foxo forkhead transcription factors
Marta L. Hribal1,
Jun Nakae1,
Tadahiro Kitamura1,
John R. Shutter2 and
Domenico Accili1
1 Naomi Berrie Diabetes Center, Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY 10032
2 Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, CA 91320
Address correspondence to Domenico Accili, Russ Berrie Research Pavilion, Rm. 238, 1150 St. Nicholas Ave., New York, NY 10032. Tel.: (212) 851-5332. Fax: (212) 851-5331. email: da230{at}columbia.edu
Insulin-like growth factors promote myoblast differentiation through phosphoinositol 3-kinase and Akt signaling. Akt substrates required for myogenic differentiation are unknown. Forkhead transcription factors of the forkhead box gene, group O (Foxo) subfamily are phosphorylated in an insulin-responsive manner by phosphatidylinositol 3-kinasedependent kinases. Phosphorylation leads to nuclear exclusion and inactivation. We show that a constitutively active Foxo1 mutant inhibits differentiation of C2C12 cells and prevents myotube differentiation induced by constitutively active Akt. In contrast, a transcriptionally inactive mutant Foxo1 partially rescues inhibition of C2C12 differentiation mediated by wortmannin, but not by rapamycin, and is able to induce aggregation-independent myogenic conversion of teratocarcinoma cells. Inhibition of Foxo expression by siRNA resulted in more efficient differentiation, associated with increased myosin expression. These observations indicate that Foxo proteins are key effectors of Akt-dependent myogenesis.
Key Words: myogenesis; growth factors; insulin signaling; phosphorylation; serine kinases
Abbreviations used in this paper: Foxo, forkhead box gene, group O; IGF, insulin-like growth factor; MyHC, myosin heavy chain; PI 3-kinase, phosphatidylinositol 3-kinase; RD, rhabdomyosarcoma-derived.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Martinez, S. C., Tanabe, K., Cras-Meneur, C., Abumrad, N. A., Bernal-Mizrachi, E., Permutt, M. A.
(2008). Inhibition of Foxo1 Protects Pancreatic Islet {beta}-Cells Against Fatty Acid and Endoplasmic Reticulum Stress-Induced Apoptosis. Diabetes
57: 846-859
[Abstract]
[Full Text]
-
Nedachi, T., Kadotani, A., Ariga, M., Katagiri, H., Kanzaki, M.
(2008). Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes. Am. J. Physiol. Endocrinol. Metab.
294: E668-E678
[Abstract]
[Full Text]
-
Evans-Anderson, H. J., Alfieri, C. M., Yutzey, K. E.
(2008). Regulation of Cardiomyocyte Proliferation and Myocardial Growth During Development by FOXO Transcription Factors. Circ. Res.
102: 686-694
[Abstract]
[Full Text]
-
Wu, A.-L., Kim, J.-H., Zhang, C., Unterman, T. G., Chen, J.
(2008). Forkhead Box Protein O1 Negatively Regulates Skeletal Myocyte Differentiation through Degradation of Mammalian Target of Rapamycin Pathway Components. Endocrinology
149: 1407-1414
[Abstract]
[Full Text]
-
De Alvaro, C., Nieto-Vazquez, I., Rojas, J. M., Lorenzo, M.
(2008). Nuclear Exclusion of Forkhead Box O and Elk1 and Activation of Nuclear Factor-{kappa}B Are Required for C2C12-RasV12C40 Myoblast Differentiation. Endocrinology
149: 793-801
[Abstract]
[Full Text]
-
Roeb, W., Boyer, A., Cavenee, W. K., Arden, K. C.
(2007). PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. Proc. Natl. Acad. Sci. USA
104: 18085-18090
[Abstract]
[Full Text]
-
Biswas, S. C., Shi, Y., Sproul, A., Greene, L. A.
(2007). Pro-apoptotic Bim Induction in Response to Nerve Growth Factor Deprivation Requires Simultaneous Activation of Three Different Death Signaling Pathways. J. Biol. Chem.
282: 29368-29374
[Abstract]
[Full Text]
-
Southgate, R. J., Neill, B., Prelovsek, O., El-Osta, A., Kamei, Y., Miura, S., Ezaki, O., McLoughlin, T. J., Zhang, W., Unterman, T. G., Febbraio, M. A.
(2007). FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle. J. Biol. Chem.
282: 21176-21186
[Abstract]
[Full Text]
-
Frost, R. A., Lang, C. H.
(2007). Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J. Appl. Physiol.
103: 378-387
[Abstract]
[Full Text]
-
Wilson, E. M., Rotwein, P.
(2007). Selective Control of Skeletal Muscle Differentiation by Akt1. J. Biol. Chem.
282: 5106-5110
[Abstract]
[Full Text]
-
Birkenkamp, K. U., Essafi, A., van der Vos, K. E., da Costa, M., Hui, R. C.-Y., Holstege, F., Koenderman, L., Lam, E. W.-F., Coffer, P. J.
(2007). FOXO3a Induces Differentiation of Bcr-Abl-transformed Cells through Transcriptional Down-regulation of Id1. J. Biol. Chem.
282: 2211-2220
[Abstract]
[Full Text]
-
Liu, T.-J., Lai, H.-C., Ting, C.-T., Wang, P. H
(2007). Bidirectional regulation of upstream IGF-I/insulin receptor signaling and downstream FOXO1 in cardiomyocytes. J Endocrinol
192: 149-158
[Abstract]
[Full Text]
-
Allen, D. L., Unterman, T. G.
(2007). Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am. J. Physiol. Cell Physiol.
292: C188-C199
[Abstract]
[Full Text]
-
He, H.-J., Zhu, T.-N., Xie, Y., Fan, J., Kole, S., Saxena, S., Bernier, M.
(2006). Pyrrolidine Dithiocarbamate Inhibits Interleukin-6 Signaling through Impaired STAT3 Activation and Association with Transcriptional Coactivators in Hepatocytes. J. Biol. Chem.
281: 31369-31379
[Abstract]
[Full Text]
-
Kawamori, D., Kaneto, H., Nakatani, Y., Matsuoka, T.-a., Matsuhisa, M., Hori, M., Yamasaki, Y.
(2006). The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation. J. Biol. Chem.
281: 1091-1098
[Abstract]
[Full Text]
-
Droge, W.
(2005). Oxidative Aging and Insulin Receptor Signaling. J. Gerontol. A Biol. Sci. Med. Sci.
60: 1378-1385
[Abstract]
[Full Text]
-
Puig, O., Tjian, R.
(2005). Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev.
19: 2435-2446
[Abstract]
[Full Text]
-
Bois, P. R. J., Brochard, V. F., Salin-Cantegrel, A. V. A., Cleveland, J. L., Grosveld, G. C.
(2005). FoxO1a-Cyclic GMP-Dependent Kinase I Interactions Orchestrate Myoblast Fusion. Mol. Cell. Biol.
25: 7645-7656
[Abstract]
[Full Text]
-
de Alvaro, C., Martinez, N., Rojas, J. M., Lorenzo, M.
(2005). Sprouty-2 Overexpression in C2C12 Cells Confers Myogenic Differentiation Properties in the Presence of FGF2. Mol. Biol. Cell
16: 4454-4461
[Abstract]
[Full Text]
-
Kim, C.-H., Xiong, W. C., Mei, L.
(2005). Inhibition of MuSK Expression by CREB Interacting with a CRE-Like Element and MyoD. Mol. Cell. Biol.
25: 5329-5338
[Abstract]
[Full Text]
-
Bastie, C. C., Nahle, Z., McLoughlin, T., Esser, K., Zhang, W., Unterman, T., Abumrad, N. A.
(2005). FoxO1 Stimulates Fatty Acid Uptake and Oxidation in Muscle Cells through CD36-dependent and -independent Mechanisms. J. Biol. Chem.
280: 14222-14229
[Abstract]
[Full Text]
-
Kyoung Kim, H., Kyoung Kim, Y., Song, I.-H., Baek, S.-H., Lee, S.-R., Hye Kim, J., Kim, J.-R.
(2005). Down-Regulation of a Forkhead Transcription Factor, FOXO3a, Accelerates Cellular Senescence in Human Dermal Fibroblasts. J. Gerontol. A Biol. Sci. Med. Sci.
60: 4-9
[Abstract]
[Full Text]
-
Sasson, I. E., Stern, M. J.
(2004). FGF and PI3 kinase signaling pathways antagonistically modulate sex muscle differentiation in C. elegans. Development
131: 5381-5392
[Abstract]
[Full Text]
-
Accili, D.
(2004). Lilly Lecture 2003: The Struggle for Mastery in Insulin Action: From Triumvirate to Republic. Diabetes
53: 1633-1642
[Abstract]
[Full Text]
-
NANDI, A., KITAMURA, Y., KAHN, C. R., ACCILI, D.
(2004). Mouse Models of Insulin Resistance. Physiol. Rev.
84: 623-647
[Abstract]
[Full Text]